ATYR PHARMA INC's ticker is and the CUSIP is 002120902. A total of 2 filers reported holding ATYR PHARMA INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $0 | -100.0% | 100 | -99.8% | 0.00% | – |
Q2 2023 | $106 | +1414.3% | 49,500 | +1314.3% | 0.00% | – |
Q1 2023 | $7 | +16.7% | 3,500 | +20.7% | 0.00% | – |
Q4 2022 | $6 | -99.9% | 2,900 | -14.7% | 0.00% | – |
Q3 2022 | $10,000 | -61.5% | 3,400 | -63.8% | 0.00% | – |
Q2 2022 | $26,000 | -67.9% | 9,400 | -38.6% | 0.00% | – |
Q1 2022 | $81,000 | +12.5% | 15,300 | +57.7% | 0.00% | – |
Q4 2021 | $72,000 | +176.9% | 9,700 | +86.5% | 0.00% | – |
Q3 2021 | $26,000 | +4.0% | 5,200 | -1.9% | 0.00% | – |
Q2 2021 | $25,000 | – | 5,300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
SIMPLEX TRADING, LLC | 5,300 | $25,000 | 0.00% |